Literature DB >> 1648249

Neoplastic disease of the spine.

T J Masaryk1.   

Abstract

In summary, MR imaging has become the single most effective modality for the evaluation of spinal neoplasms by virtue of its ability to image the spinal cord directly and noninvasively. In this fashion, one can localize mass lesions relative to the spinal cord; in conjunction with the patient's clinical history, it is thus possible to provide a brief yet accurate differential diagnosis. Intravenous paramagnetic contrast enhancement also may prove extremely useful in further delineating such lesions. In addition, it has demonstrated a high sensitivity to primary and secondary tumors of the bony spine through its ability to detect subtle T1 signal changes in the vertebral marrow space.

Entities:  

Mesh:

Year:  1991        PMID: 1648249

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  5 in total

1.  Atypical presentation of a giant spinal schwannoma.

Authors:  Wen-Shan Sung; Jeeuk Song; Arvind Dubey
Journal:  BMJ Case Rep       Date:  2010-09-20

2.  Removal of intradural-extramedullary spinal cord tumors with unilateral limited laminectomy.

Authors:  Jong-Eun Sim; Seung-Jin Noh; Young-Jin Song; Hyung-Dong Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-05-20

Review 3.  Imaging of primary bone tumors of the spine.

Authors:  Antonios Drevelegas; Danai Chourmouzi; Glikeria Boulogianni; Ioannis Sofroniadis
Journal:  Eur Radiol       Date:  2002-09-25       Impact factor: 5.315

4.  Experience of operative treatment in 27 patients with intraspinal neurilemmoma.

Authors:  Haibo Li; Yiping Weng; Dong Zhou; Luming Nong; Nanwei Xu
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

5.  Spinal Tumors and Tumor-like Masses: Relevance of Initial Imaging, Karnofsky Performance Status, Age, Location, and Cord Edema.

Authors:  Surendra Kumar Gupta; Sonal Gahlot; Richa Singh; Virendra Singh
Journal:  J Clin Imaging Sci       Date:  2019-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.